<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05066425</url>
  </required_header>
  <id_info>
    <org_study_id>21839</org_study_id>
    <nct_id>NCT05066425</nct_id>
  </id_info>
  <brief_title>Soluble Corn Fiber for Promoting Executive Function Study</brief_title>
  <acronym>SCOPE</acronym>
  <official_title>Soluble Corn Fiber for Promoting Executive Function Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tate and Lyle Ingredients Americas LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching aim of this study is to test the influence of daily consumption of a soluble&#xD;
      corn fiber (SCF) known i.e., PROMITOR® Soluble Fibre™ for cognitive function among middle and&#xD;
      older-aged adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although regular consumption of soluble dietary fiber has been shown to support multiple&#xD;
      markers of gastrointestinal and physical health, the effects of regular fiber consumption for&#xD;
      promoting cognitive health remain unclear. Additionally, the GI microbiota-dependent&#xD;
      mechanisms by which dietary fiber may impact markers of cognitive function remain&#xD;
      understudied. Thus, the overarching aim of this study is to test the influence of daily&#xD;
      consumption of a soluble corn fiber (SCF) known i.e., PROMITOR® Soluble Fibre™ for cognitive&#xD;
      function among middle and older-aged adults. The primary hypothesis is that daily consumption&#xD;
      of dietary fiber over a period of 4 weeks will significantly improve executive function. The&#xD;
      secondary hypothesis is that the influence of SCF on cognitive outcomes will be mediated by&#xD;
      improvement in GI bacterial taxa and fermentation-end product profiles. These hypotheses will&#xD;
      be tested by conducting a 4 week randomized, double-blind, placebo-controlled cross-over&#xD;
      study among healthy, i.e., free-living cognitively intact middle-aged and older adults&#xD;
      between45-75 years of age. This work is significant because most Americans do not meet their&#xD;
      recommended dietary fiber intake and there is a growing interest in understanding the&#xD;
      potential benefits of consuming dietary fiber for broader health outcomes including both&#xD;
      gastrointestinal and cognitive health.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attention Accuracy</measure>
    <time_frame>4 weeks</time_frame>
    <description>Behavioral performance measured as accuracy (%) during Flanker task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attention Reaction Time</measure>
    <time_frame>4 weeks</time_frame>
    <description>Behavioral performance measured as response time (ms) during Flanker task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>P3 Amplitude</measure>
    <time_frame>4 weeks</time_frame>
    <description>Amplitude (microvolt) of the P3 ERP waveform assessed during the Flanker task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Event-related potentials</measure>
    <time_frame>4 weeks</time_frame>
    <description>Latency (ms) of the P3 ERP waveform assessed during the Flanker task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relational Memory</measure>
    <time_frame>4 weeks</time_frame>
    <description>Accuracy during a spatial reconstruction task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Microbiota</measure>
    <time_frame>4 weeks</time_frame>
    <description>Taxonomic compositionprofiles of the gastrointestinal microbiota</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Metabolites</measure>
    <time_frame>4 weeks</time_frame>
    <description>Quantity of short-chain fatty acids in fecal samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood/Well-being</measure>
    <time_frame>4 weeks</time_frame>
    <description>Total score on surveys (POMS, PANAS, SF-36)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Health</condition>
  <arm_group>
    <arm_group_label>Soluble Corn Fiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>22g Soluble Corn Fiber/day for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>22g Maltodextrin/day for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soluble Corn Fiber</intervention_name>
    <description>Participants will be asked to consume a packet of 22g Soluble Corn Fiber/day for 4 weeks</description>
    <arm_group_label>Soluble Corn Fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maltodextrin</intervention_name>
    <description>Participants will be asked to consume a packet of 22g Maltodextrin/day for 4 weeks</description>
    <arm_group_label>Maltodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 45-75 years of age&#xD;
&#xD;
          2. Free of cognitive impairment (Mini-Mental State Examination score of higher than 24)&#xD;
&#xD;
          3. Absence of neurological disease&#xD;
&#xD;
          4. Absence of gastrointestinal diseases&#xD;
&#xD;
          5. Absence of prediabetes or diabetes&#xD;
&#xD;
          6. No color blindness&#xD;
&#xD;
          7. Have normal or corrected-to-normal vision&#xD;
&#xD;
          8. No history of antibiotics or smoking over the past 3 months&#xD;
&#xD;
          9. Agree to refrain from taking pre-or probiotic supplements during the study&#xD;
&#xD;
         10. Agree to inform researchers of any changes in chronic medications during the study&#xD;
&#xD;
         11. Body Mass Index (BMI) between 18.5 to 34.9 kg/m2&#xD;
&#xD;
         12. Habitual dietary fiber consumption of ≤12g/d (women) and ≤19 g/d (men) based on DHQ II&#xD;
&#xD;
         13. Not consuming an extreme dietary pattern (e.g., vegan, keto, low FODMAP)&#xD;
&#xD;
         14. No allergies to corn or maltodextrin, eggs, peanuts, tree nuts, wheat and soy&#xD;
&#xD;
         15. Agree to maintain habitual dietary patterns throughout the study period&#xD;
&#xD;
         16. Maintain their current level of physical activity&#xD;
&#xD;
         17. Complete all necessary study questionnaires and to provide stool specimens as&#xD;
             required.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &lt;45 or &gt;75 years of age&#xD;
&#xD;
          2. Presence of cognitive impairment (Mini-Mental State Examination score of lower than&#xD;
             24)&#xD;
&#xD;
          3. Presence of neurological disease&#xD;
&#xD;
          4. Presence of gastrointestinal diseases&#xD;
&#xD;
          5. Presence of prediabetes or diabetes&#xD;
&#xD;
          6. Color blindness&#xD;
&#xD;
          7. Non normal or uncorrected vision&#xD;
&#xD;
          8. History of antibiotics or smoking over the past 3 months&#xD;
&#xD;
          9. Not agree to refrain from taking pre- or probiotic supplements during the study&#xD;
&#xD;
         10. Not agree to communicate any changes in chronic medications during the study&#xD;
&#xD;
         11. Body Mass Index (BMI) below 18.5 or greater than 34.9 kg/m2&#xD;
&#xD;
         12. Habitual dietary fiber consumption of &gt;12g/d (women) and &gt;19 g/d (men) based on DHQ II&#xD;
&#xD;
         13. Consuming an extreme dietary pattern (e.g., vegan, keto, low FODMAP)&#xD;
&#xD;
         14. Allergies to corn and/or maltodextrin&#xD;
&#xD;
         15. Not agree to maintain habitual dietary patterns throughout the study period&#xD;
&#xD;
         16. Not agree to maintain their current level of physical activity&#xD;
&#xD;
         17. Not agree to complete all necessary study questionnaires and to provide stool&#xD;
             specimens as required.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Illinois at Urbana-Champaign</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naiman A Khan, PhD, RD</last_name>
      <phone>217-300-2197</phone>
      <email>nakhan2@illinois.edu</email>
    </contact>
    <investigator>
      <last_name>Naiman A Khan, PhD, RD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Microbiota</keyword>
  <keyword>Cognition</keyword>
  <keyword>Fiber</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

